Lipsin

Lipsin Brand names, Lipsin Analogs

Lipsin Brand Names Mixture

No information avaliable

Lipsin Chemical_Formula

C₂₀H₂₁ClO₄

Lipsin RX_link

http://www.rxlist.com/cgi/generic3/fenofibrate.htm

Lipsin fda sheet

Lipsin FDA

Lipsin msds (material safety sheet)

Lipsin MSDS

Lipsin Synthesis Reference

No information avaliable

Lipsin Molecular Weight

360.831 g/mol

Lipsin Melting Point

80.5 °C

Lipsin H₂O Solubility

0.25mg/ml at 25 °C

Lipsin State

Solid

Lipsin LogP

5.575

Lipsin Dosage Forms

Capsule; Tablet

Lipsin Indication

For use as adjunctive therapy to diet to reduce elevated LDL-C, Total-C,Triglycerides and Apo B, and to increase HDL-C in adult patients with primary hypercholesterolemia or mixed dyslipidemia (Fredrickson Types IIa and IIb)

Lipsin Pharmacology

Fenofibrate is a lipid regulating agent indicated as adjunctive therapy to diet to reduce elevated LDL-C, Total-C,Triglycerides and Apo B, and to increase HDL-C in adult patients with primary hypercholesterolemia or mixed dyslipidemia (Fredrickson Types IIa and IIb). Fenofibrate is also indicated as adjunctive therapy to diet for treatment of adult patients with hypertriglyceridemia (Fredrickson Types IV and V hyperlipidemia). Fenofibric acid, the active metabolite of Fenofibrate, produces reductions in total cholesterol, LDL cholesterol, apolipoprotein B, total triglycerides and triglyceride rich lipoprotein (VLDL) in treated patients. In addition, treatment with fenofibrate results in increases in high density lipoprotein (HDL) and apoproteins apoAI and apoAII.

Lipsin Absorption

Fenofibrate is well absorbed from the gastrointestinal tract. After absorption, fenofibrate is mainly excreted in the urine in the form of metabolites, primarily fenofibric acid and fenofibric acid glucuronide

Lipsin side effects and Toxicity

LD₅₀=1600 mg/kg (Oral, in mice); Investigated as a teratogen and reproductive hazard.

Lipsin Patient Information